Organization
King Saud university Medical City
2 abstracts
Abstract
Predictors of survival outcome of TAS102 combined with bevacizumab compared to TAS102 alone in Saudi patients with metastatic colorectal cancer beyond second line of systemic therapy.Org: Makkah Saudi Arabia, King Abdulla Medical City/Makkah, Mekkah, Umm AlQura University, King Abdulaziz Medical City (NGHA),
Abstract
ASSOCIATION BETWEEN RED BLOOD CELLS DISTRIBUTION WIDTH AND CARDIOVASCULAR RISK IN OSTEOARTHRITISOrg: Assiut University, Rheumatology & Rehabilitation, BHRUT, King Khalid University Hospital, King Saud university Medical City, South Egypt Cancer Institute,